Cargando…
Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081484/ https://www.ncbi.nlm.nih.gov/pubmed/35527350 http://dx.doi.org/10.1002/jev2.12219 |
| _version_ | 1784702996198719488 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9081484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90814842022-05-13 Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants J Extracell Vesicles Erratum John Wiley and Sons Inc. 2022-05-08 2022-05 /pmc/articles/PMC9081484/ /pubmed/35527350 http://dx.doi.org/10.1002/jev2.12219 Text en © 2022 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles. |
| spellingShingle | Erratum Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants |
| title | Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants |
| title_full | Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants |
| title_fullStr | Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants |
| title_full_unstemmed | Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants |
| title_short | Erratum: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants |
| title_sort | erratum: a bacterial extracellular vesicle‐based intranasal vaccine against sars‐cov‐2 protects against disease and elicits neutralizing antibodies to wild‐type and delta variants |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081484/ https://www.ncbi.nlm.nih.gov/pubmed/35527350 http://dx.doi.org/10.1002/jev2.12219 |